1Enlund F, Nordkvist A, Sahlin P, et al. Expression of PLAGI and HMGIC proteins and fusion transcripts in radiation-associated pleomorphic adenomas [J]. Int J Oncol,2002,20(4):713-716.
2Voz ML, Astrom AK, Kas K, et al. The recurrent translocation t(5;8)(p13;q12) in pleomorphic adenomas results in upregulation of PLAG1 gene expression under control of the LIFR promoter [J]. Oncogene,1998, 16(11):1409-1416.
3Kas K, Voz ML, Roijer E, et al. Promoter swapping between the genes for a novel zinc finger protein and betacatenin in pleiomorphic adenomas with t (3;8)(p21;q12) translocations [J]. Nat Genet,1997,15(2):170-174.
4Astrom AK, Voz ML, Kas K, et al. Conserved mechanism of PLAG1 activation in salivary gland tumors with and without chromosome 8q12 abnormalities: identification of SII as a new fusion partner gene [J]. Cancer Res,1999,59 (4): 918-923.
5Kas K, Voz ML, Hensen K, et al. Transcriptional activation capacity of the novel PLAG family of zinc finger proteins [J]. J Biol Chem,1998, 273(36): 23026-23032.
6Van Dyck F, Declercq J, Braem CV, et al. PLAG1, the prototype of the PLAG gene family: Versatility in tumour development (review) [J]. Int J Oncol, 2007,30(4):765-774.
7Asp J, Persson F, Kost-Alimova M, et al. CHCHD7- PLAG1 and TCEA1-PLAG1 gene fusions resulting from cryptic, intrachromosomal 8q rearrangements in pleomorphic salivary gland adenomas [J]. Genes Chromosomes Cancer, 2006,45(9):820-828.
8Khandwala HM, McCutcheon IE, Flyvbjerg A, et al. The effects of insulin-like growth factors on tumorigenesis and neoplastic growth [J]. Endocr Rev,2000,21(3):215-244.
9Hensen K, Van Valckenborgh IC, Kas K, et al. The tumorigenic diversity of the three PLAG family members is associated with different DNA binding capacities [J]. Cancer Res, 2002,62(5): 1510-1517.
10Declercq J, Van Dyck F, Braem CV, et al. Salivary gland tumors in transgenic mice with targeted PLAG1 protooncogene overexpression [J]. Cancer Res, 2005,65(11): 4544-4553.
5Qi M, Ikematsu S, Ichihara-Tanaka K, et al. Midkine rescues Wilms' tumor cells from cisplatin-induced apoptosis: regulation of Bcl2 expression by midkine [J]. J Biochem, 2000,127(2):269-277.
6Goto H, Kawano K, Kobayashi I, et al. Expression of cyclin D1 and GSK-3beta and their predictive value of prog-nosis in squamous cell carcinomas of the tongue [J].Oral Oneol, 2002,38(6) :549-56.
7Tekant Y, Davydova J, Ramirez PJ, et al. Oncolytic adenoviral therapy in gallbladder carcinoma[J]. Surgery,2005, 137(5): 527-535.
8Yoshida Y, Tomizawa M, Bahar R, et al. A promoter region of midkine gene can activate transcription of an exogenous suicide gene in human pancreatic cancer[J]. Anticancer Res,2002,22(1A): 117-120.
9Tomizawa M, Yu L Wada A, et al. A promoter region of the midkine gene that is frequently expressed in human hepatocellular carcinoma can activate a suicide gcne as effectively as the alpha-fetoprotein promoter[J]. Br J Cancer,2003, 89(6): 1086-1090.
10Ikematsu S, Okamoto K, Yoshida Y, et al. High levels of urinary midkine in various cancer patients[J]. Biochem Biophys Res Commun,2003,306(2): 329-332.
